Sign up to save your podcasts
Or
Share Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
View all episodes
By American Academy of Neurology
4.7
285285 ratings
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
More shows like Neurology® Podcast
View all
NEJM This Week
317 Listeners
JAMA Clinical Reviews
496 Listeners
Practical Neurology Podcast
51 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
JAMA Neurology Author Interviews
12 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
Neurology Today in 5
23 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
512 Listeners
Neurology Minute
134 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Neurology Exam Prep Podcast
190 Listeners
The Curious Clinicians
372 Listeners
Ninja Nerd
318 Listeners
Continuum Audio
81 Listeners